RA Capital Management »

Mbx Biosciences shares owned by RA Capital Management

Quarter-by-quarter ownership of Mbx Biosciences shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Mbx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Mbx Biosciences held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mbx Biosciences by RA Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $39M 1.5M 25.98

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Vaxcyte SH (PCVX)
Janux Therapeutics SH (JANX)
Legend Biotech Corp- SH (LEGN)
Rhythm Pharmaceuticals SH (RYTM)
Avidity Biosciences SH (RNA)
Tyra Biosciences SH (TYRA)
Evolent Health Inc - A SH (EVH)
Edgewise Therapeutics SH (EWTX)
Biogen SH (BIIB)
Dyne Therapeutics SH (DYN)
Rxsight SH (RXST)
Bicara Therapeutics SH
Climb Bio SH (ELYM)
Ars Pharmaceuticals SH (SPRY)

View all positions for RA Capital Management

Top funds holding Mbx Biosciences

Frazier Life Sciences Management
OrbiMed Advisors
NEA Management Company
NVP Associates
RA Capital Management
T. Rowe Price Associates
Driehaus Capital Management
Woodline Partners
Franklin Resources
Alyeska Investment Group
Platinum Investment Mangement
Citadel Advisors
Stempoint Capital
Monashee Investment Management
TD Asset Management

View all funds holding Mbx Biosciences